These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 11208846

  • 1. Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin.
    Rosenthal MA, Kavar B, Hill JS, Morgan DJ, Nation RL, Stylli SS, Basser RL, Uren S, Geldard H, Green MD, Kahl SB, Kaye AH.
    J Clin Oncol; 2001 Jan 15; 19(2):519-24. PubMed ID: 11208846
    [Abstract] [Full Text] [Related]

  • 2. Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma.
    Hill JS, Kahl SB, Kaye AH, Stylli SS, Koo MS, Gonzales MF, Vardaxis NJ, Johnson CI.
    Proc Natl Acad Sci U S A; 1992 Mar 01; 89(5):1785-9. PubMed ID: 1542672
    [Abstract] [Full Text] [Related]

  • 3. Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer.
    Hill JS, Kahl SB, Stylli SS, Nakamura Y, Koo MS, Kaye AH.
    Proc Natl Acad Sci U S A; 1995 Dec 19; 92(26):12126-30. PubMed ID: 8618857
    [Abstract] [Full Text] [Related]

  • 4. Boronated protoporphyrin (BOPP): localization in lysosomes of the human glioma cell line SF-767 with uptake modulated by lipoprotein levels.
    Callahan DE, Forte TM, Afzal SM, Deen DF, Kahl SB, Bjornstad KA, Bauer WF, Blakely EA.
    Int J Radiat Oncol Biol Phys; 1999 Oct 01; 45(3):761-71. PubMed ID: 10524433
    [Abstract] [Full Text] [Related]

  • 5. Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model.
    Ozawa T, Afzal J, Lamborn KR, Bollen AW, Bauer WF, Koo MS, Kahl SB, Deen DF.
    Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):247-52. PubMed ID: 16111595
    [Abstract] [Full Text] [Related]

  • 6. Phase I and pharmacokinetic study of KRN8602 alone and with filgrastim in patients with advanced cancer.
    Clarke K, Basser RL, Maher D, Morgan DJ, Cebon J, Fox RM, Hill JS, Alt C, Bartlett J, Geldard H, Kaye AH, Green MD.
    J Clin Oncol; 1998 Jun 01; 16(6):2181-7. PubMed ID: 9626219
    [Abstract] [Full Text] [Related]

  • 7. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.
    Lilge L, Wilson BC.
    J Clin Laser Med Surg; 1998 Apr 01; 16(2):81-91. PubMed ID: 9663099
    [Abstract] [Full Text] [Related]

  • 8. Phase I and pharmacokinetic study of a daily times 5 short intravenous infusion schedule of 9-aminocamptothecin in a colloidal dispersion formulation in patients with advanced solid tumors.
    Herben VM, van Gijn R, Schellens JH, Schot M, Lieverst J, Hillebrand MJ, Schoemaker NE, Porro MG, Beijnen JH, ten Bokkel Huinink WW.
    J Clin Oncol; 1999 Jun 01; 17(6):1906-14. PubMed ID: 10561232
    [Abstract] [Full Text] [Related]

  • 9. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.
    Mukai H, Wada Y, Watanabe Y.
    Ann Nucl Med; 2013 Aug 01; 27(7):625-39. PubMed ID: 23605059
    [Abstract] [Full Text] [Related]

  • 10. A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma.
    Morganti AG, Balducci M, Salvati M, Esposito V, Romanelli P, Ferro M, Calista F, Digesù C, Macchia G, Ianiri M, Deodato F, Cilla S, Piermattei A, Valentini V, Cellini N, Cantore GP.
    Int J Radiat Oncol Biol Phys; 2010 May 01; 77(1):92-7. PubMed ID: 19683876
    [Abstract] [Full Text] [Related]

  • 11. Promising survival in patients with high-grade gliomas following therapy with a novel boronated porphyrin.
    Rosenthal MA, Kavar B, Uren S, Kaye AH.
    J Clin Neurosci; 2003 Jul 01; 10(4):425-7. PubMed ID: 12852879
    [Abstract] [Full Text] [Related]

  • 12. A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model.
    Ceberg CP, Brun A, Kahl SB, Koo MS, Persson BR, Salford LG.
    J Neurosurg; 1995 Jul 01; 83(1):86-92. PubMed ID: 7782856
    [Abstract] [Full Text] [Related]

  • 13. Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies.
    Ryan DP, Supko JG, Eder JP, Seiden MV, Demetri G, Lynch TJ, Fischman AJ, Davis J, Jimeno J, Clark JW.
    Clin Cancer Res; 2001 Feb 01; 7(2):231-42. PubMed ID: 11234874
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic drug interaction between AEE788 and RAD001 causing thrombocytopenia in patients with glioblastoma.
    Reardon DA, Cloughesy T, Rich J, Alfred Yung WK, Yung L, DiLea C, Huang J, Dugan M, Mietlowski W, Maes A, Conrad C.
    Cancer Chemother Pharmacol; 2012 Jan 01; 69(1):281-7. PubMed ID: 21984222
    [Abstract] [Full Text] [Related]

  • 19. Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
    Murren J, Modiano M, Clairmont C, Lambert P, Savaraj N, Doyle T, Sznol M.
    Clin Cancer Res; 2003 Sep 15; 9(11):4092-100. PubMed ID: 14519631
    [Abstract] [Full Text] [Related]

  • 20. SarCNU, a nitrosourea analog on a day 1, 5, and 9 oral schedule: a phase I and pharmacokinetic study in patients with advanced solid tumors.
    Panasci L, Stinson SF, Melnychuk D, Sandor V, Miller WH, Batist G, Patenaude F, Bangash N, Panarello L, Alaoui-Jamali M, Sausville E.
    J Clin Oncol; 2003 Jan 15; 21(2):232-40. PubMed ID: 12525514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.